Results 81 to 90 of about 1,947,723 (297)

National Drugs Advisory Board annual report, 1990.

, 1990
The National Drugs Advisory Board was established by the Minister for Health in 1966 by the National Drugs Advisory Board (Establishment) Order 1966 (5.1. No.163 of 1966) under the Health (Corporate Bodies) Act 1961.
National Drugs Advisory Board (NDAB)
core  

SMART-Plant project flyer (H2020)

, 2016
Scale-up of low-carbon footprint MAterial Recovery Techniques in existing wastewater treatment PLANTs SMART-plant aims to support the water sector to improve and ensure environmental protection, become more adaptive, and respond to contemporary ...
SMART-Plant Consortium, SMART-Plant Consortium (5292223)   +1 more
core   +1 more source

SMART: A process-oriented methodology for resilient smart cities [PDF]

, 2016
Cities are engines of economic prosperity and social development. Rapid urbanization and the impacts of climate change have resulted in increased vulnerabilities in cities.
Mourshed, Monjur, Khandokar, Fahmida, Fahmida Khandokar, Bucchiarone, Antonio, Monjur Mourshed, M. Mourshed, Antonio Bucchiarone, F. Khokar   +7 more
core   +1 more source

Nanoamphizymes: Self‐Assembled Amphiphilic Enzymatic Nanomaterials for High‐Performance Biocatalysis and Biosensing

Advanced Functional Materials, EarlyView.
An amphiphilic GOx nanoamphizyme was constructed by covalently introducing hydrophobic PPNI linkers onto GOx, enabling spontaneous self‐assembly into tunable nanoparticles. Mild crosslinking further stabilized the assemblies and enhanced catalytic performance and stability.
Yuan‐Hao Hsiao, Rajan Deepan Chakravarthy, Po‐Hsiang Chen, Abdelreheem Abdelfatah Saddik, Hsin‐Chieh Lin   +4 more
wiley   +1 more source

National Drugs Advisory Board annual report, 1986

, 1986
The National Drugs Advisory Board was established by the Minister for Health in 1966 by the National Drugs Advisory Board (Establishment) Order 1966 (5.1. No. 163·of 1966) under the Health (Corporate Bodies) Act 1961.
National Drugs Advisory Board (NDAB)
core  

Reports of side effects associated with the use of drugs 1991 [PDF]

, 1991
In order that drugs for therapeutic use should be given under the best and safest circumstances, it is important that practitioners be aware of potential hazards in their use.
National Drugs Advisory Board (NDAB)
core  

Microfluidic Nano‐Assembly of Red‐Blood‐Cell (RBC) Lipids and Components for Engineering Extracellular Vesicles

Advanced Healthcare Materials, EarlyView.
Engineered red blood cell‐derived extracellular vesicles (eRBCEVs) are synthesized via controlled microfluidic assembly from native RBC lipids, enabling tunable encapsulation of proteins, nucleic acids, nanoparticles, and viral vectors. The platform demonstrates reproducible nanoscale architecture, preserved membrane composition, and functional cargo ...
Chiranth K. Nagaraj, Xilal Y. Rima, Kim T. Nguyen, Courtney Culkins, Nana Boateng, Jacob Doon‐Ralls, Alejandro Bresolin, Xin Huang, Hong Li, Vahedi Amid, Ajeet Pal Singh, Dharti Shantaram, Anastasiia Amari, Mangesh D. Hade, Nicholas R. Merriam, Zachary D. Schultz, Scott Q. Harper, Nizar Y. Saad, Setty M. Magaña, Willa A. Hsueh, Rachel E. Kopec, Blaise R. Kimmel, Andre F. Palmer, Eduardo Reátegui   +23 more
wiley   +1 more source

National Drugs Advisory Board annual report and accounts, 1994

, 1994
The National Drugs Advisory Board was established by the Minister for Health in 1966 by the National Drugs Advisory Board (Establishment) Order 1966 (5.1. No. 163 of 1966) under the Health (Corporate Bodies) Act 1961.
National Drugs Advisory Board (NDAB)
core  

Microfluidic Engineering of Microgels: A Review of Emerging Technologies, Materials, Fabrication Strategies, and Applications

Advanced Healthcare Materials, EarlyView.
Recent advances in microfluidic technologies for microgel fabrication are critically reviewed, highlighting the capabilities and limitations of major microfluidic platforms and discussing how platform design, material selection, and crosslinking strategies influence microgel architecture and functionality. Current challenges and future opportunities in
Afshin Abrishamkar, Laura Neely, Cynthia Pham, Nada Ibrahim, Alexis Larios‐Cervantes, Ben A. Kertesz, Todd Hoare   +6 more
wiley   +1 more source

AS SMART DRUGS E O DIREITO DAS RELAÇÕES DE CONSUMO: UMA ANÁLISE DOS LIMITES LEGAIS DO APRIMORAMENTO COGNITIVO

Revista de Ciências Jurídicas e Sociais da UNIPAR
O presente artigo examina o uso de smart drugs para aprimoramento cognitivo e suas implicações legais no contexto das relações de consumo. O objetivo é analisar a comercialização de nootrópicos, que frequentemente é realizada de maneira ilegal no ...
Fabrício Germano Alves, Júllia Andrade de Castro   +1 more
doaj   +1 more source